23 research outputs found

    Evidence-based national vaccine policy

    Get PDF
    India has over a century old tradition of development and production of vaccines. The Government rightly adopted self-sufficiency in vaccine production and self-reliance in vaccine technology as its policy objectives in 1986. However, in the absence of a full-fledged vaccine policy, there have been concerns related to demand and supply, manufacture vs. import, role of public and private sectors, choice of vaccines, new and combination vaccines, universal vs. selective vaccination, routine immunization vs. special drives, cost-benefit aspects, regulatory issues, logistics etc. The need for a comprehensive and evidence based vaccine policy that enables informed decisions on all these aspects from the public health point of view brought together doctors, scientists, policy analysts, lawyers and civil society representatives to formulate this policy paper for the consideration of the Government. This paper evolved out of the first ever ICMR-NISTADS national brainstorming workshop on vaccine policy held during 4-5 June, 2009 in New Delhi, and subsequent discussions over email for several weeks, before being adopted unanimously in the present form

    Abstracts of National Conference on Research and Developments in Material Processing, Modelling and Characterization 2020

    Full text link
    This book presents the abstracts of the papers presented to the Online National Conference on Research and Developments in Material Processing, Modelling and Characterization 2020 (RDMPMC-2020) held on 26th and 27th August 2020 organized by the Department of Metallurgical and Materials Science in Association with the Department of Production and Industrial Engineering, National Institute of Technology Jamshedpur, Jharkhand, India. Conference Title: National Conference on Research and Developments in Material Processing, Modelling and Characterization 2020Conference Acronym: RDMPMC-2020Conference Date: 26–27 August 2020Conference Location: Online (Virtual Mode)Conference Organizer: Department of Metallurgical and Materials Engineering, National Institute of Technology JamshedpurCo-organizer: Department of Production and Industrial Engineering, National Institute of Technology Jamshedpur, Jharkhand, IndiaConference Sponsor: TEQIP-

    Global Burden of Cardiovascular Diseases and Risks, 1990-2022

    Full text link
    The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) is a multinational collaborative research study with >10,000 collaborators around the world. GBD generates a time series of summary measures of health, including prevalence, cause-specific mortality (CSMR), years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs) to provide a comprehensive view of health burden for a wide range of stakeholders including clinicians, public and private health systems, ministries of health, and other policymakers. These estimates are produced for 371 causes of death and 88 risk factors according to mutually exclusive, collectively exhaustive hierarchies of health conditions and risks. The study is led by a principal investigator and governed by a study protocol, with oversight from a Scientific Council, and an Independent Advisory Committee.1 GBD is performed in compliance with Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER).2 GBD uses de-identified data, and the waiver of informed consent was reviewed and approved by the University of Washington Institutional Review Board (study number 9060). This almanac presents results for 18 cardiovascular diseases (CVD) and the CVD burden attributed to 15 risk factors (including an aggregate grouping of dietary risks) by GBD region. A summary of methods follows. Additional information can be found online at https://ghdx.healthdata.org/record/ihme-data/cvd-1990-2022, including:Funding was provided by the Bill and Melinda Gates Foundation, and the American College of Cardiology Foundation. The authors have reported that they have no relationships relevant to the contents of this paper to disclose. The contents and views expressed in this report are those of the authors and do not necessarily reflect the official views of the National Institutes of Health, the Department of Health and Human Services, the U.S. Government, or the affiliated institutions

    Observation of the Ξb\Xi^-_\mathrm{b}\toψ\psi(2S)Ξ\Xi^- decay and studies of the Ξb0\Xi_\mathrm{b}^{\ast{}0} baryon in proton-proton collisions at s\sqrt{s} = 13 TeV

    Full text link
    The first observation of the decay Ξb\Xi^-_\mathrm{b}\toψ\psi(2S)Ξ\Xi^- and measurement of the branching ratio of Ξb\Xi^-_\mathrm{b}\toψ\psi(2S)Ξ\Xi^- to Ξb\Xi^-_\mathrm{b}\to J/ψ\psiΞ\Xi^- are presented. The J/ψ\psi and ψ\psi(2S) mesons are reconstructed using their dimuon decay modes. The results are based on proton-proton colliding beam data from the LHC collected by the CMS experiment at s\sqrt{s} = 13 TeV in 2016-2018, corresponding to an integrated luminosity of 140 fb1^{-1}. The branching fraction ratio is measured to be B\mathcal{B}(Ξb\Xi^-_\mathrm{b}\toψ\psi(2S)Ξ\Xi^-)/B\mathcal{B}(Ξb\Xi^-_\mathrm{b}\to J/ψ\psiΞ\Xi^-) = 0.840.19+0.21^{+0.21}_{-0.19} (stat) ±\pm 0.10 (syst) ±\pm 0.02 (B\mathcal{B}), where the last uncertainty comes from the uncertainties in the branching fractions of the charmonium states. New measurements of the Ξb0\Xi_\mathrm{b}^{\ast{}0} baryon mass and natural width are also presented, using the Ξbπ+\Xi_\mathrm{b}^-\pi^+ final state, where the Ξb\Xi^-_\mathrm{b} baryon is reconstructed through the decays J/ψΞ\psi \Xi^-, ψ\psi(2S)Ξ\Xi^-, J/ψΛ\psi \LambdaK^-, and J/ψΣ0\psi \Sigma^0K^-. Finally, the fraction of the Ξb\Xi^-_\mathrm{b} baryons produced from Ξb0\Xi_\mathrm{b}^{\ast{}0} decays is determined
    corecore